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Abstract: Infectious diseases remain as the significant causes of human and animal morbidity and mortality, leading to extensive
outbreaks and epidemics. Acute respiratory viral diseases claim over 4 million deaths and cause millions of hospitalizations in developing
countries every year. Emerging viruses, especially the RNA viruses, are more pathogenic since most people have no herd immunity.
The RNA viruses can adapt to the rapidly changing global and local environment due to the high error rate of their polymerases that
replicate their genomes. Currently, coronavirus disease 2019 (COVID-19) is determined as an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in 2019 in Wuhan. Herein we discuss emerging and
reemerging respiratory viral infections till to SARS-CoV-2.
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1. Introduction
Infectious diseases that increase in incidence and tend to
spread geographically within decades can be defined as
emerging infections. Pathogens of these infections appear
for the first time or they have existed previously and spread
rapidly among the population and new geographical
areas. The emergence of novel human pathogens and
reemergence of several diseases is of particular concerns
of the current century [1]. There is a dominance of
zoonotic infections, mostly originating in wildlife, among
emerging health threats with a rate of 70%. Pathogens first
emerge in themselves and rapidly mutate, which result in
a transmission in humans with subsequent dissemination.
According to the extent of the transmission, epidemic
outbreaks may occur and progress to a pandemic.
Diseases that reappear after a significant decline are called
as reemerging diseases. Reemergence may occur due to a
breakdown in public health measures or the appearance of
new strains of organisms [2]. Respiratory infections with
epidemic and pandemic potential that cause a global burden
have plagued people since the beginning of human history.
In this review, the epidemic and pandemic, emerging and
reemerging respiratory viruses are summarized in Table.
Most emerging viruses come from animals and are
zoonotic or vector-borne diseases belonging to the families
Orthomyxoviridae, Paramyxoviridae, Picornaviridae,

Coronaviridae,
Adenoviridae,
and
Herpesviridae.
Community-acquired respiratory viruses are critical
pathogens such as influenza, respiratory syncytial virus,
adenovirus, parainfluenza virus, human coronavirus,
human metapneumovirus, rhinovirus, enterovirus, cause
millions of deaths and hospitalizations around all over the
world every year [3,4].
In the last century, influenza originated avian, and
swine, severe acute respiratory syndrome-coronavirus
(SARS-CoV) and the Middle East respiratory syndromecoronavirus (MERS-CoV) were the most damaging
respiratory infections for human being all over the world
[5]. These emerging viral respiratory infections derived
from the animal world [6]. Mutations in the genetic
material of RNA viruses accumulate in years and produce
new strains of the viruses with new antigenic properties
resulting in a transmission in humans [7]. The probability
of pandemics with new viruses would be high in the future
as this type of mutations will reoccur.
The other mechanism of a virus is reassortment which
means that the host is infected with 2 different strains of
viruses (animal and human viruses) than a new generation
of a new virus with mixed genetic materials is developed
and causes new pandemics [7]. Bird and swine influenza
viruses obtain new gene segments through a reassortment
with human strains.
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Table. Outbreaks of emerging and reemerging respiratory viral infections.
Virus

Year

Region

Spanish Flu H1N1

1918

Spain [25]

Asian flu H2N2

1956

East Asia [28]

HCoV-229E HCoV-OC43

1960

The different part of the World [29]

Hong Kong Flu H3N2

1968

Hong Kong [28]

Hantavirus pulmonary syndrome

1993

USA [16]

Influenza A H5N1

1997

Hong Kong [28]

Influenza A H9N2

1999

Hong Kong [28]

Human metapneumovirus

2001

Netherlands [18]

SARS CoV

2002–2003

Guangdong, China [22]

Human CoV NL63

2004

Netherlands [20]

Influenza A H7N7

2004

Netherlands [28]

Human CoV HKU1

2005

China [20]

Triple reassortant H3N2 Influenza A

2005

Canada [28]

Bocavirus

2005

Sweden [19]

Influenza A H1N1 pmd09

2009

Mexico [28]

Adenovirus 14

2010

USA [30]

Influenza (H3N2)v

2011

USA [9]

MERS-CoV

2012

Saudi Arabia [23]

Influenza A H7N9

2013

China [28]

Influenza A H10N7

2014

China [28]

SARS-CoV-2

2019

China [26]

The mutation in the genetic material of RNA-virus
also sometimes drifts in time and builds a chimeric virus,
containing nucleic acid fragments or proteins from 2 or
more different viruses. This novel hybrid virus is different
from parental viruses [8].
Currently, COVID-19 caused by a zoonotic virus
severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) was first determined in 2019 in Wuhan, the capital
of China’s Hubei province. Epidemiologic data show
exposures of some initial cases in Huanan seafood and live
animal market and early phylogenetic results suggest initial
human infection in November 2019 followed by ongoing
human-to-human transmission. Animal source has not
been identified yet; and COVID-19 has since spread globally,
resulting in the current 2019–2020 coronavirus pandemic.
The majority of cases (approximately 96%) occur with mild
respiratory symptoms, some progress to pneumonia, acute
respiratory distress syndrome, respiratory insufficiency
and multi-organ failure. The overall rate of deaths per
number of diagnosed cases is 4.6%; ranging from 0.2% to
15% according to age group and other health problems.
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2. Emerging and reemerging viruses in the last century
2.1. Influenza viruses
The influenza viruses are the world’s most critical
epidemic viruses. Influenza pandemics occurred earlier
in 1918 (swine flu), 1957 (Asian flu), 1968 (Hong Kong
flu), 1977 (Russian flu), and the most recent pandemic
in 2009 (pandemic influenza A H1N1) [9]. It belongs to
the Orthomyxoviridae family. Influenza is an enveloped
virus with negative-stranded RNA consists of 8 segments.
There are 4 different types; A, B, C, and D [7, 10].
Influenza A virions possess 2 surface glycoproteins—the
hemagglutinin (HA) and neuraminidase (NA)-which
exert different functions. Eighteen hemagglutinin and
11 neuraminidase subtypes are known to exist in nature
[10]. They can infect birds and mammals, including man.
Influenza B is restricted to human horde. Influenza C is
isolated from humans, pigs and dogs [10]. Influenza D
viruses primarily affect cattle and human population
in all age groups [11]. Seasonal influenza viruses kill
250,000–500,000, mostly older people each year around
the world [3].
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2.2. H1N1 influenza
Influenza virus type A is very variable and shows a
continuous antigen variation. It is a significant cause
of epidemics and pandemics. The surface antigenic
glycoproteins are subject to 2 main types of antigenic
variation, namely: antigenic shift and antigenic drift.
The antigen shift is an abrupt, significant change in an
influenza A virus that leads to new HA and/or new HA
and NA proteins in influenza viruses that infect man. The
interruption can lead to a novel influenza A subtype in
humans. These are small changes (or mutations) in the
genes of influenza viruses that can guide to alterations in
the surface proteins of the virus: HA (hemagglutinin) and
NA (neuraminidase). The HA and NA surface proteins of
influenza viruses are “antigens”, which implies that they are
seen by the immune system and can activate an immune
response, including the production of antibodies that can
halt the contagion. The changes associated with antigen
drift occur continuously over time as the virus replicates.
Most flu shots target the HA surface proteins/antigens of
an influenza virus.
The most fatal and unforgettable outbreak “mother of
the pandemic” virus occurred in 1918 named as Spanish
influenza. In this eruption, approximately 50 million
people [12, 13] were dead. H1N1 was occurred in different
years (1928, 1932, 1936, 1943, 1947) during this century
[7].
In 1977, H1N1 was reemerged and named as Russian
flu, which mostly affected young people. In 2009, H1N1
was the reason of a new pandemic. It was first detected in
the USA. This one delivered an unparalleled combination
of influenza genes with a triple reassortment [7].
2.3. H2N2 influenza
In 1957, a new strain appeared in the world named H2N2,
emerged in humans in Southeast Asia and rapidly spread
worldwide. The virus persists in wild and domestic birds.
The reemergence of H2N2 in humans is a significant threat
due to the absence of humoral immunity, and it was the
case of the second pandemic of the 20th century [14].
2.4. Avian influenza (AI)
Humans are susceptible to avian influenza virus
subtypes-A (H5N1), A (H7N9) and A (H9N2). Exposure
to infected birds or contaminated environment is thought
to underlie human infection with these viruses. There
have been sporadic cases of human infections with AI and
other zoonotic influenza viruses, but sustained humanto-human infection and transmission have been lacking.
Although the public health risk from the currently known
influenza viruses at the human-animal interface remains
the same, the sustained human-to-human transmission
of this virus is low. Avian influenza A viruses (AIVs) are
among a terrifying emerging and reemerging pathogen
because of their possible risk of causing an influenza

pandemic. The growth in domestic animals and poultry
worldwide is followed by the ascent of human AIV
outbreaks [3].
The risk of death is highest among reported cases
infected with H5N1, H5N6, H7N9, and H10N8 infections.
Senior people and males tended to take in a lower hazard
of infection with most AIV subtypes, except for H7N9.
Visiting live poultry markets were generally reported by
H7N9, H5N6, and H10N8 cases, while exposure to sick or
dead bird mostly reported by H5N1, H7N2, H7N3, H7N4,
H7N7, and H10N7 cases [15].
2.5. Hantavirus
Hantavirus pulmonary syndrome (HPS) has emerged
from the infection with Sin Nombre virus (SNV). It is a
negative-sensed, single-stranded RNA virus. The virus
was first identified in the United States in 1995. Since
then, 71 people were diagnosed as HPS, and all patients
were California residents. Persons were usually exposed to
SNV through inhalation of aerosolized excreta (e.g., saliva,
urine, and faeces) from infected wild animals (rodents,
typically deer mice). HPS has demonstrated a severe
disease characterized by pulmonary oedema, followed by
respiratory failure than cardiogenic shock [16,17].
2.6. Human metapneumovirus (HMPV)
HMPV is a negative-sense, single-stranded RNA virus
of the family Pneumoviridae, cause of acute respiratory
infection, particularly in children, immunocompromised
patients, and the aged. HPMV genome was mostly
similar to avian metapneumovirus serotype C. In 2001,
researchers in the Netherlands identified HMPV from
nasopharyngeal samples from 28 children. The virus is a
leading cause of acute respiratory infection, particularly in
children, immunocompromised patients, and the elderly.
Almost every child is infected with HMPV by the age of
5 [18].
2.7. Bocavirus
Human bocavirus (HBoV) is a member of
the Parvovirus (DNA) family, detected in 2005. It is
distributed worldwide, and evidence indicates that HBoV
is the cause of the respiratory tract infections. Numerous
studies demonstrate HBoV as a co-pathogen. Studies prove
that its prevalence in asymptomatic patients is high [19].
2.8. Coronavirus
The Coronaviridae family includes a broad spectrum of
animal and human viruses, with typical morphology.
Before 2003, the virus family was known as the cause of
only mild respiratory illness in humans. However, the
emergence of severe acute respiratory virus (SARS-CoV)
and MERS-CoV shows the zoonotic potential of causing
severe disease outbreaks in humans [20].
Coronaviruses also have the largest positive-sense RNA
genome, which is expressed by a complicated procedure.
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This genomic type allows the formation of encrypting RNA
transcripts in a genome. Somehow, encrypted sequences
are progressing during the replication cycle and produce
new types of coronavirus. Coronaviruses are classified into
3 groups, grounded on the antigenic properties of virus
proteins: the spike (S), membrane (M), and nucleocapsid
(N) proteins [20].
2.8.1. HCoV-229E and HcoV-OC43
Human virus HCoV-229E is one of the species in
genus alphacoronavirus, and it is the first group. It is
the first coronavirus, isolated from patients with upper
respiratory tract infections in the 1965. Until late 2002,
only 2 human coronaviruses were very well known–
HCoV-229E and HCoV-OC43. HCoV-OC43 is from the
genus betacoronavirus, and it is in the second group of
coronaviruses. HCoV-OC43 also isolates from patients
with upper respiratory tract infections.
HCoV 229E and OC43 are the known causes of the
common cold within the last 200 years. They are now
globally endemic in humans, crossed species from their
animal reservoirs (bats and cattle, respectively) to humans
[20].
2.8.2. Severe acute respiratory syndrome coronavirus
(SARS-CoV)
Severe acute respiratory syndrome (SARS) has emerged
initially from ancestral bat viruses. SARS-CoV was
the ﬁrst known major pandemic coronavirus. The
disease occurred in late 2002 when an outbreak of acute
community-acquired atypical pneumonia syndrome was
first diagnosed in Guangdong Province, China. Over 8000
people were affected, with a crude fatality rate of 10% in
more than 12 countries [21].
The WHO issued a worldwide warning about the
disease on March 13, 2003. Although the cases generally
remained confined to China, a few cases were reported
from North and South America, Europe and Asia. Luckily,
new cases with SARS has not been described since 2004
[22].
2.8.3. Middle east respiratory syndrome coronavirus
(MERS-CoV)
MERS-CoV is a zoonotic viral disease that causes
respiratory infection. It was first reported in Saudi Arabia
in 2012 and has expanded to 26 different countries. Since
2012, over 2207 laboratory-confirmed cases and 787 deaths
from MERS-CoV infection have occurred worldwide.
The clinical spectrum of illness associated with MERSCoV ranges from asymptomatic infections to acute
respiratory distress syndrome, resulting in multi-organ
failure and mortality. The case-fatality rates have stayed
high at 3–4 per 10 cases [23].
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Francis and his colleagues (2007) were mentioned
around the emergency of newly reemerging coronaviruses.
Due to coronaviruses genetic recombination, newly
emerged ones may go to new genotypes and outbreaks.
They specially indicated the reservoir (horseshoe bats)
of SARS-CoV-like viruses as a source of novel types of
coronaviruses, because of the culture of eating exotic
mammals in southern China. They said that it is a time
bomb of the possibility of the reemergence of SARS [20].
2.8.4. SARS-CoV-2
In December 2019, a novel coronavirus (SARS-CoV-2)
was observed in 3 patients with pneumonia connected to
the cluster of acute respiratory illness cases from Wuhan,
China. By the end of March 2020, the virus spread all over the
globe and caused a large global outbreak [24]. On January
30 2020, the WHO declared the COVID-19 outbreak as the
sixth public health emergency of international concern,
following H1N1 (2009), polio (2014), Ebola in West Africa
(2014), Zika (2016) and Ebola in the Democratic Republic
of Congo (2019) [25,26]. WHO announced a COVID-19
outbreak as pandemic on Mar 12, 2020.
SARS- CoV-2 was found to be a positive-sense,
single-stranded RNA virus belonging to the genus
Betacoronavirus, closely related to 2 bats-derived severe
acute respiratory syndrome-like coronaviruses, bat-SLCoVZC45 and bat-SL-CoVZXC21 [24,27].
Although early studies reported a possible link between
animal-to-human transmission, later studies demonstrated
human-to-human transmission of SARS-CoV-2 through
droplets or direct contact. Besides symptomatic patient
transmission, there are shreds of evidence of the possibility
of transmission by asymptomatic carriers [26].
3. Conclusion
The emerging and reemerging respiratory virus infections
are a continuing threat to human life [10]. Reassortment,
chimerism, antigenic shift, antigenic drift, and other
molecular mechanisms cause new epidemic and pandemic
of coronaviruses. RNA viruses are much more vulnerable to
a chromosome mutation mechanism [7,10] as an outcome
of ecological change [10]. Human-animal interface [31],
changing environment and tropical deforestation [32],
rapidly increasing population, increasing international
travel, immigrants and poverty enhance the spread of viral
disease around the world [33].
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